Clinical Trials Browser

Phase 2 × INDUSTRY × matuzumab × Clear all

NCT00215644 2018-11-02

MATRIX EG

Phase 2 Completed

72 enrolled 7 charts

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

NCT00111839 2018-04-06

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

Phase 2 Completed

150 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00073541 2017-01-20

A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer

Phase 2 Completed

Ovarian Neoplasms